Entity Common Stock, Shares Outstanding of BridgeBio Pharma, Inc. from 09 Aug 2019 to 12 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
BridgeBio Pharma, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 09 Aug 2019 to 12 Feb 2026.
  • BridgeBio Pharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 12 Feb 2026 was 193,862,871, a 1.9% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

BridgeBio Pharma, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 193,862,871 +3,674,245 +1.9% 12 Feb 2026 10-K 24 Feb 2026 2025 FY
Q3 2025 192,708,813 +3,719,011 +2% 21 Oct 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 191,168,504 +3,135,766 +1.7% 29 Jul 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 189,880,720 +2,751,460 +1.5% 22 Apr 2025 10-Q 29 Apr 2025 2025 Q1
Q4 2024 190,188,626 13 Feb 2025 10-K 20 Feb 2025 2024 FY
Q3 2024 188,989,802 +15,022,750 +8.6% 05 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 188,032,738 +25,560,339 +16% 25 Jul 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 187,129,260 +26,628,261 +17% 25 Apr 2024 10-Q 02 May 2024 2024 Q1
Q3 2023 173,967,052 +24,483,918 +16% 26 Oct 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 162,472,399 +14,226,090 +9.6% 31 Jul 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 160,500,999 +12,807,141 +8.7% 24 Apr 2023 10-Q 04 May 2023 2023 Q1
Q3 2022 149,483,134 +2,316,561 +1.6% 28 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 148,246,309 -1,519,105 -1% 29 Jul 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 147,693,858 -1,590,326 -1.1% 29 Apr 2022 10-Q 05 May 2022 2022 Q1
Q3 2021 147,166,573 +24,598,357 +20% 29 Oct 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 149,765,414 +27,403,770 +22% 30 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 149,284,184 +25,518,719 +21% 30 Apr 2021 10-Q 06 May 2021 2021 Q1
Q3 2020 122,568,216 -1,006,751 -0.82% 30 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 122,361,644 +5,606,132 +4.8% 05 Aug 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 123,765,465 24 Feb 2020 10-K 03 Mar 2020 2019 FY
Q3 2019 123,574,967 05 Nov 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 116,755,512 09 Aug 2019 10-Q 14 Aug 2019 2019 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.